Results: 935 news stories
The Sam and Ann Barshop Institute for Longevity and Aging Studies at ¸£ÀûÒ»ÇøÔÚÏß, will receive up to $38 million to lead a national clinical trial funded by the Advanced Research Projects Agency for Health (ARPA-H), an agency of the U.S. Department of Health and Human Services.
A large, retrospective study conducted by scientists at The University of Texas at San Antonio suggests that people taking glucagon-like peptide-1 (GLP-1) receptor agonists — medications that are widely prescribed for metabolic disease — have a significantly lower risk of developing colorectal cancer compared with those taking aspirin.
San Antonio Business Journal: UT San Antonio lands nearly $40M in new fed funding
San Antonio Report: Ukraine army doctors visit San Antonio on medical exchange trip
The Detroit News: Is autism preventable in certain cases after all? Some scientists say yes.
The Boston Globe: Is autism preventable in certain cases after all? Some scientists say yes.
MSN.com: Is autism preventable in certain cases after all? Some scientists say yes.
Washington Post: Is autism preventable in certain cases after all? Some scientists say yes.
News Medical: Grant supports research into how microglia may spread toxic tau in Alzheimer’s
Sarah C. Hopp, PhD, associate professor, Department of Pharmacology, was mentioned in this article. Read More
Science Magazine: ¸£ÀûÒ»ÇøÔÚÏß Researcher Awarded Grant to Investigate Role of Brain Immune Cells in Alzheimer’s Disease
KVDA-TV (Telemundo 60 San Antonio): Doctora explica procedimientos para detectar los tipos de cáncer más comunes
KABB TV (Fox SA): Road to Gold — International Childhood Cancer Day celebrates perseverance of young patients
Texas Public Radio: ¸£ÀûÒ»ÇøÔÚÏß holds conference to boost cancer research among Latino populations
Ellen Kraig, PhD, professor in the Department of Cell Systems and Anatomy in the Joe R. and Teresea Lozano Long School of Medicine at the University of Texas at San Antonio (UT San Antonio), has been named a Distinguished Fellow of the American Association of Immunologists (AAI). The AAI Distinguished Fellow designation recognizes members with […]
San Antonio Report: Colon cancer increase in young people is ‘very alarming,’ San Antonio doctors say
San Antonio Express-News: Ignore those singing Super Bowl toilets, here’s what your pee color really means
Associated Press: Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of BSI-082
John Sarantopoulos, MD, associate professor, Department of Medicine, Division of Hematology and Oncology, and medical oncologist, Mays Cancer Center, was mentioned in this article. Read More
MSN.com: Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours